With pharmaceutical companies marching inexorably toward successfully developing a COVID-19 vaccine, debate has erupted over who will have the eventual rights of ownership and pricing

Within the last decade, the genome editor known as CRISPR-Cas9, short for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9, has become one

Abstract: 

For years, lawyers, technologists, and digital rights activists have denounced the Computer Fraud and Abuse Act (“CFAA”) as vague, dangerous, and overbroad. Broad interpretations of

As the novel coronavirus continues to spread and affect people across the world, countries are beginning to use technology to try and limit the spread

Pharmacy Workers Turn to Makeshift Virus Protections on the Job

Pharmacy workers are taking steps to protect themselves from exposure to the coronavirus, including putting

As we enter week four since President Trump recognized the COVID-19 outbreak as a global pandemic and a national emergency,[1] many wonder when

Amazon Threatened with Lawsuit by NY and “Sick Out” Protests at WholeFoods Nationwide

An Amazon employee, Chris Smalls, was fired Monday March

Palantir Provides COVID-10 Software to CDC and NHS, Pitches European Health Agencies

Amidst the coronavirus pandemic, Palantir has teamed up with the CDC

Due to the COVID-19 pandemic, on advice of healthcare officials and sometimes, mandated by governments, people throughout the world are locking down and traveling less. 

Patent Protection Should Take a Backseat in a Crisis

Scott Duke Kominers argues for Bloomberg Opinion that the U.S. government should purchase or